Life Technologies to Market Gen-Probe's Aneuploidy Kits

Mar 23, 2010

NEW YORK (GenomeWeb News) – Life Technologies will commercialize Gen-Probe's Elucigene QST*R aneuploidy test kits under the Applied Biosystems name in certain markets around the world, the firm announced over the weekend.

Life Technologies will sell the test kits in Eastern Europe, Asia, Africa, Australia, Latin America, and Canada, under the agreement. However, the kits will not be available for sale in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Making a Mark

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Optimistic, Though Cautious

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

And Maybe a Fee

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

Nature Highlights Study Finding Differences in Infant Gut Microbiome by Delivery Mode, More

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.

Featured White Papers

Delivering Precision Health: the Role of Molecular Diagnostics

BlueBee Data Security & Compliance

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Oct

10

Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct

21

Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Genomics is a key element in the potential of precision medicine to transform oncology.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu